No association of CNR1 gene variations with susceptibility to schizophrenia

[1]  D. Deutsch,et al.  2-Arachidonoylglycerol (2-AG) membrane transport: History and outlook , 2008, The AAPS Journal.

[2]  J. Gelernter,et al.  CNR1 Variation Modulates Risk for Drug and Alcohol Dependence , 2007, Biological Psychiatry.

[3]  A. Heinz,et al.  Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis , 2007, Neuropsychopharmacology.

[4]  T. Werge,et al.  Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebusmonkeys , 2006, Journal of psychopharmacology.

[5]  J. Hoenicka,et al.  (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[6]  M. Krebs,et al.  (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population , 2006, The Pharmacogenomics Journal.

[7]  W. Hall.  Is cannabis use psychotogenic? , 2006, The Lancet.

[8]  N. Craddock,et al.  Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. , 2005, Schizophrenia bulletin.

[9]  T. Freund,et al.  Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia , 2005, Behavioural pharmacology.

[10]  M. Iyo,et al.  A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia , 2005, Neuroscience Letters.

[11]  Ralitza Gueorguieva,et al.  Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction , 2005, Biological Psychiatry.

[12]  B. Cravatt,et al.  Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. , 2004, Biochemistry.

[13]  H. Ujike,et al.  New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.

[14]  H Ujike,et al.  CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.

[15]  N. Griffon,et al.  Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. , 2001, American journal of medical genetics.

[16]  M. Fritzsche.  Are cannabinoid receptor knockout mice animal models for schizophrenia? , 2001, Medical hypotheses.

[17]  S. Tsai,et al.  Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. , 2000, Psychiatric genetics.

[18]  K. Müller-Vahl,et al.  A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. , 1999, Molecular and cellular probes.

[19]  H. Emrich,et al.  Elevated endogenous cannabinoids in schizophrenia. , 1999, Neuroreport.

[20]  H. Emrich,et al.  Cannabinoid/anandamide system and schizophrenia: is there evidence for association? , 1998, Pharmacopsychiatry.

[21]  E. Gershon,et al.  Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. , 1997, Genomics.

[22]  D. Comings,et al.  Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.

[23]  D. Joel,et al.  The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia , 1995, Behavioural Brain Research.

[24]  T. Bonner,et al.  Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. , 1991, The New biologist.